section name header

Indications

High Alert


Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: angina pectoris, chest pain, hypotension, supraventricular arrhythmias, VENTRICULAR ARRHYTHMIAS

Derm: rash

GI: liver enzymes

Hemat: thrombocytopenia

Neuro: headache, tremor

Interactions

Drug-drug:

Availability

(Generic available)

Route/Dosage

US Brand Names

Primacor

Action

  • Increases myocardial contractility.
  • Decreases preload and afterload by a direct dilating effect on vascular smooth muscle.
Therapeutic effects:
  • Increased cardiac output (inotropic effect).

Classifications

Therapeutic Classification: inotropics

Pharmacokinetics

Absorption: IV administration results in complete bioavailability.

Distribution: Moderately distributed to tissues.

Metabolism/Excretion: 80–90% excreted unchanged by the kidneys.

Half-Life: 2.3 hr ( in renal impairment).

Time/Action Profile

(hemodynamic effects)

ROUTEONSETPEAKDURATION
IV5–15 minunknown3–6 hr

Patient/Family Teaching

Pronunciation

MILL-ri-none

Code

NDC Code